X4 Pharmaceuticals Inc.
(XFOR)
undefined
undefined%
At close: undefined
0.66
4.61%
After-hours Dec 13, 2024, 07:09 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Cash & Equivalents | 99.22M | 121.72M | 81.79M | 78.71M | 126.18M | 30.75M | 76.79M | 3.04M | 6.76M |
Short-Term Investments | 15.00M | - | - | - | - | - | - | - | - |
Long-Term Investments | - | 1.02M | 1.32M | 1.73M | 1.90M | 364.00K | 355.00K | 394.00K | 338.00K |
Other Long-Term Assets | 1.44M | 1.23M | 1.72M | 3.26M | 1.95M | 275.00K | -355.00K | 975.00K | 25.00K |
Receivables | 562.00K | 1.15M | 747.00K | 917.00K | 2.00M | 2.86M | 1.61M | 1.34M | 1.54M |
Inventory | - | - | - | - | - | - | 355.00K | 1.25M | - |
Other Current Assets | 7.30M | 5.81M | 5.34M | 3.68M | 1.10M | 1.47M | 1.13M | 1.34M | 87.00K |
Total Current Assets | 122.08M | 128.68M | 87.88M | 83.31M | 129.28M | 35.08M | 80.83M | 5.72M | 8.39M |
Property-Plant & Equipment | 6.39M | 8.33M | 10.22M | 9.20M | 2.36M | 285.00K | 421.00K | 519.00K | 760.00K |
Goodwill & Intangibles | 17.35M | 17.35M | 17.35M | 27.11M | 27.11M | - | - | - | - |
Total Long-Term Assets | 25.18M | 26.91M | 29.30M | 39.56M | 31.42M | 924.00K | 421.00K | 1.89M | 1.12M |
Total Assets | 147.26M | 155.59M | 117.18M | 122.87M | 160.70M | 36.00M | 81.25M | 7.60M | 9.51M |
Account Payables | 8.95M | 7.78M | 4.28M | 3.14M | 2.09M | 545.00K | 1.89M | 1.65M | 423.00K |
Deferred Revenue | - | - | - | - | - | 737.00K | 2.63M | 504.00K | 430.00K |
Short-Term Debt | 2.20M | 3.71M | 2.94M | 1.57M | 1.80M | 1.69M | 2.31M | 3.49M | 2.07M |
Other Current Liabilities | 11.72M | 10.84M | 6.79M | 7.23M | 5.56M | 2.43M | 5.78M | 4.78M | 3.33M |
Total Current Liabilities | 22.86M | 22.32M | 14.02M | 11.95M | 9.45M | 5.40M | 7.68M | 12.06M | 6.68M |
Long-Term Debt | 57.18M | 35.91M | 37.91M | 37.66M | 22.02M | 7.89M | 9.92M | -29.71M | -25.24M |
Other Long-Term Liabilities | 16.11M | 23.30M | 826.00K | 462.00K | 16.00K | 5.00K | 9.00K | -39.75M | -29.88M |
Total Long-Term Liabilities | 73.30M | 59.21M | 38.74M | 38.12M | 22.03M | 9.01M | 14.87M | 52.11M | 37.16M |
Total Liabilities | 96.16M | 81.53M | 52.76M | 50.07M | 31.48M | 14.40M | 22.55M | 64.17M | 43.83M |
Total Debt | 58.28M | 38.42M | 39.78M | 38.45M | 22.91M | 7.89M | 12.24M | 15.29M | 7.19M |
Common Stock | 167.00K | 122.00K | 28.00K | 16.00K | 16.00K | 15.00K | 15.00K | 1K | 1K |
Retained Earnings | -477.90M | -376.74M | -282.87M | -194.18M | -132.04M | -135.29M | -92.27M | -58.39M | -35.41M |
Comprehensive Income | -119.00K | -119.00K | -119.00K | -119.00K | -119.00K | 241.00K | 127.00K | 834.00K | 718.00K |
Shareholders Equity | 51.10M | 74.05M | 64.41M | 72.80M | 129.22M | 21.60M | 58.71M | -56.56M | -34.32M |
Total Investments | 15.00M | 1.02M | 1.32M | 1.73M | 1.90M | 364.00K | 355.00K | 394.00K | 338.00K |